Skip to content

Natural History of Asphyxiating Thoracic Dystrophy (DTJ)

Clinical and Molecular Study, Natural History of Asphyxiating Thoracic Dystrophy (DTJ)

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00948376
Acronym
DTJ
Enrollment
50
Registered
2009-07-29
Start date
2007-11-30
Completion date
2011-07-31
Last updated
2011-12-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asphyxiating Thoracic Dystrophy

Keywords

Natural history, IFT80, short ribs, multivisceral involvement

Brief summary

The aim of the project is to prospectively analyze at a clinical and molecular level a series of 50 asphyxiating thoracic dysplasia (ATD) patients and 20 fetuses to further define the natural history of the disorder and to contribute to the identification of its molecular basis.

Detailed description

Asphyxiating thoracic dysplasia (ATD, MIM 208500) belongs to the short rib polydactyly group and is characterized by short ribs often responsible for an early death due to respiratory distress, trident acetabular roof and short long bones. In the course of the disease, renal, liver and eye complications may occur. However, their frequencies are unknown. ATD is transmitted with an autosomal mode of inheritance and up till now only one gene has been identified, namely IFT80, which accounts only for a small part of ATD. The aim of our project is to prospectively analyze at a clinical and molecular level a series of 50 ATD patients and 20 fetuses to further define the natural history of the disorder and to contribute to the identification of its molecular basis.

Interventions

GENETICIFT80 screening

Natural History

Sponsors

Assistance Publique - Hôpitaux de Paris
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Short ribs with narrow thorax * Trident acetabular roof * Short hands * All ages * Informed consent signed

Exclusion criteria

* Other disease * Ellis van creveld syndrome * No social security

Design outcomes

Primary

MeasureTime frame
Natural history of asphyxiating thoracic dystrophy (ATD)3 years

Secondary

MeasureTime frame
Correlation Phenotype-Genotype3 years

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026